Japan· JP-2190009R1025
ポリスチレンスルホン酸ナトリウム
A medicinal product containing ポリスチレンスルホン酸ナトリウム, registered in Japan by 鳥居薬品, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ポリスチレンスルホン酸ナトリウム
- Manufacturer
- 鳥居薬品
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ポリスチレンスルホン酸ナトリウム in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKionexANI Pharmaceuticals, Inc.
- CanadaJAMP SODIUM POLYSTYRENE SULFONATEJAMP PHARMA CORPORATION
- GermanyAnti-Kalium NaMedice Arzneimittel Pütter Gmbh & Co. Kg
- FrancePOLYSTYRENE SULFONATE DE SODIUM SUBSTIPHARM 454 g, poudre pour suspension orale et rectaleSUBSTIPHARM
- United KingdomResonium A powderSanofi
- BelgiumKayexalate Sodium 14.99 gSanofi Belgium
- FinlandResoniumSanofi Oy
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Resonium A
- Belgium · Kayexalate Sodium
- Cyprus · Resinsodio
- Germany · Anti-Kalium Na, Elutit®-Natrium-As
- Spain · Resinsodio
- Finland · Resonium
- France · Kayexalate, Lykasty
- United Kingdom (Northern Ireland) · Resonium A
- Hungary · Resonium
- Italy · Kayexalate
- Luxembourg · Kayexalate Sodium
- Netherlands · Natriumpolystyreensulfonaat Focus, Resonium A
- Poland · Resonium A
- Portugal · Resonium
- Sweden · Resonium
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb8ec2cc-72da-4435-bf3f-570fbd626e8a GET /v1/drugs/bb8ec2cc-72da-4435-bf3f-570fbd626e8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "７６％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2190009R1025",
"category": "内用薬",
"price_yen": 6.9,
"generic_name": "ポリスチレンスルホン酸ナトリウム",
"product_name_jp": null,
"therapeutic_class": "2190",
"transitional_expiry": null
}See everything about ポリスチレンスルホン酸ナトリウム.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.